https://www.selleckchem.com/pr....oducts/Dapagliflozin
Urgent guidance is needed on the safety for providers of percutaneous tracheostomy in patients diagnosed with COVID-19. The objective of the study was to demonstrate that percutaneous dilational tracheostomy (PDT) with a period of apnea in patients requiring prolonged mechanical ventilation due to COVID-19 is safe and can be performed for the usual indications in the intensive care unit. This study involves an observational case series at a single-center medical intensive care unit at a level-1 trauma center in patients diagnosed
Curtir
Comentario
Compartilhar
